Vinva Investment Management Ltd

Position in ABBV — AbbVie Inc.

CIK 1968109 SYDNEY, C3

Position in ABBV

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$128,757,142

+$69,476,546 QoQ

Shares Held

511,672

+87.7% QoQ

Ownership

0.029%

of shares outstanding

% of Portfolio

0.86%

of 13F equity value

Holder Rank

#215

of 4,153 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Vinva Investment Management Ltd holds $708,443,081 across 10 Drug Manufacturers - General names. ABBV ranks #2 (18.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	180,920	$217,000,893
2	ABBV	AbbVie Inc. This page	511,672	$128,757,142
3	JNJ	Johnson & Johnson	450,629	$114,446,247
4	BMY	Bristol Myers Squibb Co	1,870,866	$107,799,298
5	AMGN	Amgen Inc	131,323	$47,554,684
6	GILD	Gilead Sciences, Inc.	318,895	$40,289,194
7	MRK	Merck & Co., Inc.	298,766	$38,391,431
8	PFE	Pfizer Inc	510,661	$12,296,716

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$128,757,142	511,672	+87.7%	Shares	Sole	2026-08-14
2026-03-31	$59,280,596	272,567	+13.6%	Shares	Sole	2026-05-14
2025-12-31	$54,844,454	240,030	+47.6%	Shares	Sole	2026-02-17
2025-09-30	$37,644,699	162,584	+24.0%	Shares	Sole	2025-11-13
2025-06-30	$24,340,907	131,133	+40.3%	Shares	Sole	2025-08-13
2025-03-31	$19,585,301	93,477	+1.5%	Shares	Sole	2025-05-14
2024-12-31	$16,372,034	92,133	+1.7%	Shares	Sole	2025-02-11
2024-09-30	$17,898,599	90,635	+12.3%	Shares	Sole	2024-11-14
2024-06-30	$13,841,320	80,698	-0.7%	Shares	Sole	2024-08-13
2024-03-31	$14,794,168	81,242	+3.5%	Shares	Sole	2024-05-13
2023-12-31	$12,167,159	78,513	+10.9%	Shares	Sole	2024-02-13
2023-09-30	$10,554,789	70,809	+33.5%	Shares	Sole	2023-11-13
2023-06-30	$7,148,369	53,057	-10.1%	Shares	Sole	2023-08-14
2023-03-31	$9,405,061	59,014	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.